225 related articles for article (PubMed ID: 34109316)
1. An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemia.
Bajaj J; Hamilton M; Shima Y; Chambers K; Spinler K; Van Nostrand EL; Yee BA; Blue SM; Chen M; Rizzeri D; Chuah C; Oehler VG; Broome HE; Sasik R; Scott-Browne J; Rao A; Yeo GW; Reya T
Nat Cancer; 2020 Apr; 1(4):410-422. PubMed ID: 34109316
[TBL] [Abstract][Full Text] [Related]
2. In vivo genome-wide CRISPR screening in murine acute myeloid leukemia uncovers microenvironmental dependencies.
Mercier FE; Shi J; Sykes DB; Oki T; Jankovic M; Man CH; Kfoury YS; Miller E; He S; Zhu A; Vasic R; Doench J; Orthwein A; Michor F; Scadden DT
Blood Adv; 2022 Sep; 6(17):5072-5084. PubMed ID: 35793392
[TBL] [Abstract][Full Text] [Related]
3. A stem cell reporter based platform to identify and target drug resistant stem cells in myeloid leukemia.
Spinler K; Bajaj J; Ito T; Zimdahl B; Hamilton M; Ahmadi A; Koechlein CS; Lytle N; Kwon HY; Anower-E-Khuda F; Sun H; Blevins A; Weeks J; Kritzik M; Karlseder J; Ginsberg MH; Park PW; Esko JD; Reya T
Nat Commun; 2020 Nov; 11(1):5998. PubMed ID: 33243988
[TBL] [Abstract][Full Text] [Related]
4. Unraveling therapeutic targets in acute myeloid leukemia through multiplexed genome editing CRISPR screening.
Tian Z; Octaviani S; Huang J
Expert Opin Ther Targets; 2023; 27(12):1173-1176. PubMed ID: 38069633
[No Abstract] [Full Text] [Related]
5. A genome-wide approach identifies distinct but overlapping subsets of cellular mRNAs associated with Staufen1- and Staufen2-containing ribonucleoprotein complexes.
Furic L; Maher-Laporte M; DesGroseillers L
RNA; 2008 Feb; 14(2):324-35. PubMed ID: 18094122
[TBL] [Abstract][Full Text] [Related]
6. [Exploration of novel therapeutic targets in acute myeloid leukemia via genome-wide CRISPR screening].
Yamauchi T
Rinsho Ketsueki; 2019; 60(7):810-817. PubMed ID: 31391371
[TBL] [Abstract][Full Text] [Related]
7. A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia.
Tzelepis K; Koike-Yusa H; De Braekeleer E; Li Y; Metzakopian E; Dovey OM; Mupo A; Grinkevich V; Li M; Mazan M; Gozdecka M; Ohnishi S; Cooper J; Patel M; McKerrell T; Chen B; Domingues AF; Gallipoli P; Teichmann S; Ponstingl H; McDermott U; Saez-Rodriguez J; Huntly BJP; Iorio F; Pina C; Vassiliou GS; Yusa K
Cell Rep; 2016 Oct; 17(4):1193-1205. PubMed ID: 27760321
[TBL] [Abstract][Full Text] [Related]
8. Staufen2 deficiency leads to impaired response to novelty in mice.
Popper B; Demleitner A; Bolivar VJ; Kusek G; Snyder-Keller A; Schieweck R; Temple S; Kiebler MA
Neurobiol Learn Mem; 2018 Apr; 150():107-115. PubMed ID: 29496644
[TBL] [Abstract][Full Text] [Related]
9. RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9.
Zhang M; Hyle J; Chen X; Xin Y; Jin Y; Zhang J; Yang X; Chen X; Wright S; Liu Z; Rosikiewicz W; Xu B; He L; Liu H; Ping N; Wu D; Wen F; Li C; Xu P
Genome Biol; 2024 Jan; 25(1):16. PubMed ID: 38216972
[TBL] [Abstract][Full Text] [Related]
10. Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation.
Wang E; Zhou H; Nadorp B; Cayanan G; Chen X; Yeaton AH; Nomikou S; Witkowski MT; Narang S; Kloetgen A; Thandapani P; Ravn-Boess N; Tsirigos A; Aifantis I
Cell Stem Cell; 2021 Apr; 28(4):718-731.e6. PubMed ID: 33450187
[TBL] [Abstract][Full Text] [Related]
11. STAU2 protein level is controlled by caspases and the CHK1 pathway and regulates cell cycle progression in the non-transformed hTERT-RPE1 cells.
Condé L; Gonzalez Quesada Y; Bonnet-Magnaval F; Beaujois R; DesGroseillers L
BMC Mol Cell Biol; 2021 Mar; 22(1):16. PubMed ID: 33663378
[TBL] [Abstract][Full Text] [Related]
12. Genome wide CRISPR screening reveals a role for sialylation in the tumorigenesis and chemoresistance of acute myeloid leukemia cells.
Lee DH; Kang SH; Choi DS; Ko M; Choi E; Ahn H; Min H; Oh SJ; Lee MS; Park Y; Jin HS
Cancer Lett; 2021 Jul; 510():37-47. PubMed ID: 33872695
[TBL] [Abstract][Full Text] [Related]
13. High-efficiency CRISPR induction of t(9;11) chromosomal translocations and acute leukemias in human blood stem cells.
Jeong J; Jager A; Domizi P; Pavel-Dinu M; Gojenola L; Iwasaki M; Wei MC; Pan F; Zehnder JL; Porteus MH; Davis KL; Cleary ML
Blood Adv; 2019 Oct; 3(19):2825-2835. PubMed ID: 31582391
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target.
Vujovic A; de Rooij L; Chahi AK; Chen HT; Yee BA; Loganathan SK; Liu L; Chan DCH; Tajik A; Tsao E; Moreira S; Joshi P; Xu J; Wong N; Balde Z; Jahangiri S; Zandi S; Aigner S; Dick JE; Minden MD; Schramek D; Yeo GW; Hope KJ
Blood Cancer Discov; 2023 May; 4(3):180-207. PubMed ID: 36763002
[TBL] [Abstract][Full Text] [Related]
15. Forebrain-specific, conditional silencing of Staufen2 alters synaptic plasticity, learning, and memory in rats.
Berger SM; Fernández-Lamo I; Schönig K; Fernández Moya SM; Ehses J; Schieweck R; Clementi S; Enkel T; Grothe S; von Bohlen Und Halbach O; Segura I; Delgado-García JM; Gruart A; Kiebler MA; Bartsch D
Genome Biol; 2017 Nov; 18(1):222. PubMed ID: 29149906
[TBL] [Abstract][Full Text] [Related]
16. Alternative splicing of Staufen2 creates the nuclear export signal for CRM1 (Exportin 1).
Miki T; Yoneda Y
J Biol Chem; 2004 Nov; 279(46):47473-9. PubMed ID: 15364930
[TBL] [Abstract][Full Text] [Related]
17. Systematic Identification of the RNA-Binding Protein STAU2 as a Key Regulator of Pancreatic Adenocarcinoma.
Wang X; Kuang W; Ding J; Li J; Ji M; Chen W; Shen H; Shi Z; Wang D; Wang L; Yang P
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892886
[TBL] [Abstract][Full Text] [Related]
18. Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia.
Wang E; Lu SX; Pastore A; Chen X; Imig J; Chun-Wei Lee S; Hockemeyer K; Ghebrechristos YE; Yoshimi A; Inoue D; Ki M; Cho H; Bitner L; Kloetgen A; Lin KT; Uehara T; Owa T; Tibes R; Krainer AR; Abdel-Wahab O; Aifantis I
Cancer Cell; 2019 Mar; 35(3):369-384.e7. PubMed ID: 30799057
[TBL] [Abstract][Full Text] [Related]
19. ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts.
Valletta S; Dolatshad H; Bartenstein M; Yip BH; Bello E; Gordon S; Yu Y; Shaw J; Roy S; Scifo L; Schuh A; Pellagatti A; Fulga TA; Verma A; Boultwood J
Oncotarget; 2015 Dec; 6(42):44061-71. PubMed ID: 26623729
[TBL] [Abstract][Full Text] [Related]
20. Staufen2 isoforms localize to the somatodendritic domain of neurons and interact with different organelles.
Duchaîne TF; Hemraj I; Furic L; Deitinghoff A; Kiebler MA; DesGroseillers L
J Cell Sci; 2002 Aug; 115(Pt 16):3285-95. PubMed ID: 12140260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
